Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_assertion type Assertion NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_head.
- NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_assertion description "[HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_provenance.
- NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_assertion evidence source_evidence_literature NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_provenance.
- NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_assertion SIO_000772 24518603 NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_provenance.
- NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_assertion wasDerivedFrom befree-2016 NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_provenance.
- NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_assertion wasGeneratedBy ECO_0000203 NP1154265.RAfrRyZjlZNB8u-kor5gX0s4pg4YIVVklAii78-up_cpw130_provenance.